Evidence map›Paper›PMID 38911509›Full record

ArticleeNeurologicalSci2024

A case of chronic progressive autoimmune GFAP astrocytopathy with extensive meningoencephalomyelitis and contrast enhancement on MRI.

Hironori Oka, Takumi Nakamura, Takashi Sugawara, Kunihiko Ishizawa, Masakuni Amari, Takeshi Kawarabayashi, Koichi Okamoto, Masamitsu Takatama, Satoshi Nakata, Yuhei Yoshimoto and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in eNeurologicalSci, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Hironori OkaDepartment of Neurology, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi 371-0034, Japan.
Takumi NakamuraDepartment of Neurology, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi 371-0034, Japan.
Takashi SugawaraGeriatrics Research Institute and Hospital, 3-26-8 Otomo-machi, Maebashi 371-0847, Japan.
Kunihiko IshizawaGeriatrics Research Institute and Hospital, 3-26-8 Otomo-machi, Maebashi 371-0847, Japan.
Masakuni AmariGeriatrics Research Institute and Hospital, 3-26-8 Otomo-machi, Maebashi 371-0847, Japan.
Takeshi KawarabayashiGeriatrics Research Institute and Hospital, 3-26-8 Otomo-machi, Maebashi 371-0847, Japan.
Koichi OkamotoGeriatrics Research Institute and Hospital, 3-26-8 Otomo-machi, Maebashi 371-0847, Japan.
Masamitsu TakatamaGeriatrics Research Institute and Hospital, 3-26-8 Otomo-machi, Maebashi 371-0847, Japan.
Satoshi NakataDepartment of Neurosurgery, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi 371-8511, Japan.
Yuhei YoshimotoDepartment of Neurosurgery, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi 371-8511, Japan.
Ayako YamazakiDepartment of Human Pathology, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi 371-8511, Japan.
Hideaki YokooDepartment of Human Pathology, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi 371-8511, Japan.
Akio KimuraDepartment of Neurology, Gifu University Graduate School of Medicine, 1-1 Yanagito-machi, Gifu 501-1112, Japan.
Takayoshi ShimohataDepartment of Neurology, Gifu University Graduate School of Medicine, 1-1 Yanagito-machi, Gifu 501-1112, Japan.
Yoshio IkedaDepartment of Neurology, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi 371-0034, Japan.
Mikio ShojiGeriatrics Research Institute and Hospital, 3-26-8 Otomo-machi, Maebashi 371-0847, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

•We herein present a case of chronic progressive autoimmune GFAP astrocytopathy.•Symmetrical high-intensity signals on FLAIR were observed in the white matter of the temporal and occipital lobes, lateral cerebral ventricle walls, hippocampus, amygdala, and occipital cortex, with extensive Gd enhancement in radial perivascular lesions and the ependyma in the choroid plexus.•Improvements were achieved by 4 courses of IVMP and one of IVIg.

Indexed as

Autoimmune GFAP astrocytopathyChronic progressive meningoencephalomyelitisExtensive perivascular gadolinium enhancementIntravenous immunoglobulinIntravenous methylprednisolone

Identifiers

PMID38911509
PMCPMC11192973

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.